May & Baker Nig Plc RC. 558 CONSOLIDATED AND SEPARATE FINANCIAL STATEMENTS
FOR THE PERIOD ENDED '30TH SEPTEMBER, 2025
1
UNAUDITED CONSOLIDATED STATEMENT OF PROFIT OR LOSS AND OTHER COMPREHENSIVE INCOME
FOR THE PERIOD ENDED 30th September, 2025.
Continuing operations | Note | 3 Months to September, 2 N'000 | The G 9 Months September, 2025 N'000 | roup 3 Months to September, 2024 N'000 | 9 Months September, 2024 N'000 | 3 Months to September, 2025 N'000 | The Company 6 Months 3 Months to September, 2025 September, 2024 N'000 N'000 | 6 Months September, 2024 N'000 | ||
Revenue | 5 | 10,241,847 | 29,525,378 | 7,851,044 | 21,821,614 | 8,959,707 | 26,775,789 | 7,121,881 | 19,876,592 | |
Cost of sales | (6,799,928) | (19,413,057) | (5,440,804) | (15,062,034) | (6,001,378) | (17,679,300) | (4,929,724) | (13,864,295) | ||
Gross profit | 3,441,919 | 10,112,321 | 2,410,240 | 6,759,580 | 2,958,329 | 9,096,489 | 2,192,157 | 6,012,297 | ||
Other operating income/(Loss) | 7 | (52,077) | (17,790) | (232,222) | (106,191) | (52,753) | (41,821) | (192,455) | (127,080) | |
Distribution, sales and marketing expense | (1,064,024) | (3,088,803) | (844,118) | (2,213,725) | (948,074) | (2,786,813) | (740,165) | (1,965,508) | ||
Administrative expenses | (614,846) | (1,926,837) | (644,504) | (1,549,893) | (592,261) | (1,889,091) | (626,384) | (1,501,179) | ||
Operating profit/(loss) | 1,710,972 | 5,078,891 | 689,396 | 2,889,771 | 1,365,241 | 4,378,764 | 633,153 | 2,418,530 | ||
Interest income | 8 | 172,761 | 412,840 | 103,250 | 255,790 | 157,519 | 397,598 | 91,783 | 227,354 | |
Finance costs | 10 | (147,535) | (541,651) | (157,987) | (360,702) | (136,445) | (507,536) | (143,288) | (296,724) | |
Share of proft/( Loss) of Joint Venture | 17 | (35,193) | (34,946) | (8,168) | (8,578) | - | - | - | - | |
Profit/(Loss) before tax | 1,701,006 | 4,915,135 | 626,492 | 2,776,280 | 1,386,316 | 4,268,827 | 581,649 | 2,349,159 | ||
Current tax expense | 13.1 | (544,322) | (1,572,843) | (200,477) | (888,410) | (443,622) | (1,366,025) | (186,128) | (751,731) | |
Profit for the year | 11 | 1,156,684 | 3,342,292 | 426,015 | 1,887,871 | 942,694 | 2,902,802 | 395,521 | 1,597,428 | |
Other comprehensive income: | ||||||||||
Items that will not be reclassified | ||||||||||
Asset revaluation gain net of tax | - | - | - | - | - | |||||
Total comprehensive income | 1,156,684 | 3,342,292 | 426,015 | 1,887,871 | 942,694 | 2,902,802 | 1,381,524 | 1,597,428 | ||
Earnings per share | 14. | |||||||||
Basic (kobo per share) from continuing operation | 67.04 | 193.73 | 24.69 | 109.43 | 54.64 | 168.26 | 80.08 | 92.59 | ||
Diluted (kobo per share) from continuing operation | 67.04 | 193.73 | 24.69 | 109.43 | 54.64 | 168.26 | 80.08 | 92.59 | ||
All the profit of the Group is attributable to Owners of the company as there are no non-controlling interests. The accompanying notes form an integral part of these consolidated financial statements.
2
UNAUDITED CONSOLIDATED STATEMENT OF FINANCIAL POSITION
AS AT 30th September, 2025
The Group | The Company | ||||
September | December | September | September | December | September |
2025 | 2024 | 2024 | 2025 | 2024 | 2024 |
Note | N'000 | N'000 | N'000 | N'000 | N'000 | |||
ASSETS | ||||||||
Non-current assets | ||||||||
Property, plant and equipment | 16 | 6,370,698 | 5,964,013 | 5,969,098 | 6,295,608 | 5,903,245 | 5,898,098 | |
Intangible assets | 15 | 12,305 | 13,234 | 14,142 | 12,266 | 13,149 | 14,042 | |
Investment in Joint Venture | 17 | 1,136,422 | 1,171,368 | 1,189,977 | 1,326,886 | 1,326,886 | 1,326,886 | |
Investment in subsidiaries | 18 | - | - | - - | 3,000 | 3,000 | 3,000 - | |
Total non-current assets | 7,519,425 | 7,148,615 | 7,173,217 | 7,637,759 | 7,246,280 | 7,242,026 | ||
Current assets | ||||||||
Inventories | 20 | 5,346,503 | 8,243,687 | 8,236,640 | 4,709,860 | 7,538,884 | 7,806,054 | |
Trade and other receivables | 21 | 2,785,977 | 1,620,327 | 1,505,325 | 2,597,920 | 1,413,286 | 1,274,800 | |
Other assets | 23 | 4,685,730 | 2,219,988 | 1,555,647 | 4,596,166 | 1,976,620 | 1,195,474 | |
Cash and cash equivalents | 22 | 5,416,442 | 3,223,020 | 2,750,484 | 4,756,749 | 3,126,678 | 2,431,519 | |
Total current assets | 18,234,652 | 15,307,022 | 14,048,096 | 16,660,695 | 14,055,468 | 12,707,847 | ||
Total assets | 25,754,076 | 22,455,637 | 21,221,313 | 24,298,455 | 21,301,748 | 19,949,873 | ||
Equity and Liabilities | ||||||||
Share capital | 24 | 862,617 | 862,617 | 862,617 | 862,617 | 862,617 | 862,617 | |
Share premium account | 25 | 3,012,065 | 3,012,065 | 3,012,065 | 3,012,065 | 3,012,065 | 3,012,065 | |
Retained earnings | 26 | 8,262,508 | 5,610,311 | 5,877,216 | 7,248,571 | 5,035,878 | 5,272,051 | |
Asset revaluation reserve | 26.1 | 408,144 | 408,144 | 408,144 | 408,144 | 408,144 | 408,144 | |
Total equity | 12,545,335 | 9,893,137 | 10,160,042 | 11,531,398 | 9,318,704 | 9,554,878 | ||
Non-current liabilities | ||||||||
Borrowings | 27 | 2,439,389 | 1,199,390 | 1,271,533 | 2,439,389 | 1,199,390 | 1,271,533 | |
Employee benefits | 29 | 33,649 | 32,834 | 31,492 | 33,649 | 32,834 | 31,492 | |
Deferred Income | 30 | 588,256 | 186,491 | 204,879 | 588,256 | 186,491 | 204,879 | |
Deferred tax liabilities | 13 | 1,148,421 | 1,148,418 | 986,486 | 1,139,069 | 1,139,069 | 971,688 | |
Total non-current liabilities | 4,209,715 | 2,567,132 | 2,494,390 | 4,200,363 | 2,557,784 | 2,479,592 | ||
Current liabilities | ||||||||
Trade and other payables | 28 | 3,204,249 | 5,557,265 | 3,772,925 | 2,981,787 | 5,457,468 | 3,597,215 | |
Current tax liabilities | 13 | 1,590,248 | 805,841 | 905,311 | 1,382,612 | 651,520 | 767,913 | |
Borrowings | 27 | 3,977,320 | 3,548,806 | 3,787,970 | 3,975,087 | 3,232,817 | 3,449,600 | |
Deferred Income | 30 | 227,208 | 83,456 | 100,675 | 227,208 | 83,456.00 | 100,675 | |
Total current liabilities | 8,999,026 | 9,995,368 | 8,566,881 | 8,566,694 | 9,425,261 | 7,915,403 | ||
Total liabilities | 13,208,741 | 12,562,500 | 11,061,271 | 12,767,057 | 11,983,045 | 10,394,995 | ||
Total equity and liabilities | 25,754,076 | 22,455,637 | 21,221,313 | 24,298,455 | 21,301,748 | 19,949,873 |
Mr. Ayodeji S. Aboderin Mr. Patrick Ajah
Finance Director/CFO Managing Director/CEO
FRC/2014/ICAN/00000008270 FRC/2021/003/00000023215
These Financial Statements were approved by the Board on 28 October 2025 (Lagos)
MAY & BAKER NIGERIA PLC UNAUDITED CONSOLIDATED STATEMENT OF CHANGES IN EQUITY FOR THE PERIOD ENDED 30th September, 2025.Share
capital N'000
Share
premium account N'000
Retained
earnings N'000
Revaluation
Surplus N'000
Total
N'000
Equity attributable to equity holders of the Group | ||||||||
At 1 January 2024 | 862,617 | 3,012,065 | 4,506,915 | 408,144 | 8,789,741 | |||
Right issue | - | - | - | |||||
Profit for the period | - | - | 1,887,871 | - | 1,887,871 | |||
Dividends paid | - | - | (517,570) | - | (517,570) | |||
At 30th September, 2024 | 862,617 | 3,012,065 | 5,877,216 | 408,144 | 10,160,042 | |||
At 1 January 2025 | 862,617 | 3,012,065 | 5,610,311 | 408,144 | 9,893,137 | |||
Right Issue | - | - | - | |||||
Adjustment | - | - | - | |||||
Profit for the period | - | - | 3,342,292 | - | 3,342,292 | |||
Dividends paid | - | - | (690,094) | - | (690,094) | |||
At 30th September, 2025 | 862,617 | 3,012,065 | 8,262,508 | 408,144 | 12,545,334 | |||
- | ||||||||
Equity attributable to equity | ||||||||
holders of the Company | ||||||||
At 1 January 2024 | 862,617 | 3,012,065 | 4,192,193 | 408,144 | 8,475,019 | |||
Profit for the Period | - | - | 1,597,428 | - | 1,597,428 | |||
Dividends paid | - | - | (517,570) | - | (517,570) | |||
At 30th September, 2024 | 862,617 | 3,012,065 | 5,272,051 | 408,144 | 9,554,877 | |||
At 1 January 2025 | 862,617 | 3,012,065 | 5,035,863 | 408,144 | 9,318,689 | |||
Adjustment | - | - | - | - | ||||
Profit for the Period | - | - | 2,902,802 | - | 2,902,802 | |||
Dividends paid | - | - | (690,094) | - | (690,094) | |||
At 30th September, 2025 | 862,617 | 3,012,065 | 7,248,571 | 408,144 | 11,531,397 | |||
UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30th September, 2025.
The Group | The Company | ||||||
September | December | September | September | December | September | ||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
Cash flows from operating activities | |||||||
Cash received from customers | 28,588,445 | 30,023,155 | 21,472,775 | 26,035,905 | 27,728,728 | 19,750,931 | |
Cash paid to suppliers and employees | (25,930,922) | (26,314,780) | (18,289,373) | (24,485,595) | (23,506,376) | (16,611,092) | |
Taxes paid | (788,435) | (279,703) | (282,141) | (634,933) | (210,587) | (209,587) | |
Net cash from operating activities | 1,869,087 | 3,428,673 | 2,901,261 | 915,377 | 4,011,765 | 2,930,252 | |
Cash flows from Investing activities | |||||||
Proceed from contract manufacturing | 62,277 | 41,938 | 38,982 | 62,277 | 41,938 | 38,982 | |
Other sundry income | 54,112 | 80,631 | 66,641 | 52,649 | 80,631 | 66,605 | |
Proceeds from sale of fixed assets | 8,386 | 2,133 | 12,474 | 7,346 | 1,147 | 11,488 | |
Interest received | 412,840 | 407,490 | 255,790 | 397,598 | 367,214 | 227,354 | |
Purchases of Intangible assets | (1,827) | (9,433) | (9,433) | (1,827) | (9,433) | (9,433) | |
Purchases of property, plant and equipment | (1,011,907) | (1,271,186) | (1,085,405) | (967,697) | (1,268,519) | (1,082,738) | |
Net cash used in investing activities | (476,119) | (790,365) | (720,951) | (449,654) | (828,960) | (747,742) | |
Cash flows from financing activities | |||||||
Dividends paid | (690,094) | (517,570) | (517,570) | (690,094) | (517,570) | (517,570) | |
Additions to/(Repayment of) import facility | 75,569 | (941,236) | (1,487,598) | 405,348 | (1,196,391) | (1,487,056) | |
Loan received | 2,500,000 | - | - | 2,500,000 | - | - | |
Loans repaid | (386,760) | (814,567) | (669,167) | (386,760) | (814,567) | (669,167) | |
Unclaimed dividend returned | 14,586 | 12,854 | - | 14,586 | 12,854 | - | |
Finance cost | (692,874) | (370,115) | (360,702) | (658,759) | (370,115) | (296,724) | |
Net cash used in financing activities | 820,426 | (2,630,634) | (3,035,037) | 1,184,320 | (2,885,789) | (2,970,517) | |
Net increase/(decrease) in cash and | cash | 2,213,395 | 7,673 | (854,728) | 1,650,043 | 297,016 | (788,008) |
Cash and cash equivalents at 1 January | 3,184,285 | 3,176,612 | 3,176,612 | 3,087,943 | 2,790,927 | 2,790,927 | |
Cash and cash equivalents at 30th September | 5,397,680 | 3,184,285 | 2,321,884 | 4,737,987 | 3,087,943 | 2,002,919 | |
Reconciliation of cash and bank balances to cash and cash equivalents | |||||||
Cash and bank balance | 5,416,442 | 3,223,020 | 2,750,484 | 4,756,749 | 3,126,678 | 2,431,519 | |
Bank overdrafts , commercial papers, ETC | (18,762) | (38,735) | (428,600) | (18,762) | (38,735) | (428,600) | |
5,397,680 | 3,184,285 | 2,321,884 | 4,737,987 | 3,087,943 | 2,002,919 | ||
MAY & BAKER NIGERIA PLC
UNAUDITED CONSOLIDATED STATEMENT OF CASH FLOWS FOR THE PERIOD ENDED 30th September, 2025.
Free Float Computation
Company Name: | May & Baker Nigeria Plc | |
Board Listed : | Main Board | |
Year End: | December | |
Reporting Period: | Quarter 3 Ended 30 September 2025 | |
Share Price at end of reporting period: | N16.30k (2024: N7.25K) | |
Shareholding Structure /Free Float Status | . |
Description | 30-Sep-25 | 30-Sep-24 | |||
Unit | Percentage | Unit | Percentage | ||
Issued Share Capital | 1,725,234,886 | 100.00% | 1,725,234,886 | 100% | |
Substantial Shareholdings (5% and above) | |||||
T.Y.Holdings Limited | 720,878,543 | 41.78% | 720,878,543 | 41.78% | |
Onyishi Maduka samuel | 266,564,690 | 15.45% | 266,564,690 | 15.45% | |
Total Substantial Shareholdings | 987,443,233 | 57.24% | 987,443,233 | 57.24% | |
Directors' Shareholdings | |||||
Senator Daisy Danjuma | Representing Oil Tech Nigeria Ltd Representing Osis Yukiv Ltd | 14,874,759 | 0.86% | 14,874,759 | 0.86% |
11,088,000 | 0.64% | 11,088,000 | 0.64% | ||
Mr. Patrick Ajah | 2,000 | 0.00% | 2,000 | - | |
Mr. Michael C. Odumodu (Ind Representing Seravac Nigeria Ltd Representing J.I. Odumodu | 54,134,958 | 3.14% | 54,134,958 | 3.14% | |
3,617,198 | 0.21% | 3,617,198 | 0.21% | ||
Dr. (Mrs.) Rahila Ilegbodu Representing Maydav Multi Resources Ltd Aboderin A.S | 45,073,864 | 2.61% | 45,073,864 | 2.61% | |
93,500 | 0.01% | 93,500 | 0.01% | ||
Durojaiye Kolawole Olalekan | 390,485 | 0.02% | 370,485 | 0.02% | |
Mr. Osagie Omenai | - | 0.00% | - | 0.00% | |
Other Directors' Shareholdings | 129,274,764 | 7.49% | 129,274,764 | 7.49% | |
Total Directors' Shareholdings | 1,116,717,997 | 64.73% | 1,119,578,785 | 64.73% | |
ee Float in Units and Percentage 608,516,889 35.27% 605,656,101 35.27% | |||||
Free Float in Value (N) | 9,918,825,290.70 | 4,391,006,732.25 | |||
Declaration:
May & Baker Nigeria Plc with a free float percentage of 35.27% as at 30th September, 2025, is compliant with The Exchnage's free float requirements for companies listed on the Main Board.
1 Description of business
May & Baker Nigeria Plc. was incorporated as a private limited liability company in Nigeria on December 4, 1944 and commenced business on the same date. It was listed on the Nigerian stock exchange in 1994. The company is involved in the manufacture, sale and distribution of human pharmaceuticals, human vaccines and consumer products. Registered business address is 3/5 Sapara street, Industrial Estate, Ikeja, Lagos, Nigeria
Basis of preparation
Statement of compliance
These consolidated financial statements have been prepared in accordance with International Financial Reporting Standards (IFRSs) as issued by the International Accounting Standards Board (IASB), and in compliance with Financial Reporting Council of Nigeria Act No 6 2011. Additional information required by national regulations has been included where appropriate.
These consolidated financial statements comprise of the consolidated statement of profit or loss and other comprehensive income, the consolidated statement of financial position, the consolidated and separate statement of changes in equity, the consolidated and separate statement of cashflows and notes to the consolidated financial statements.
Going concern status
These consolidated financial statements have been prepared on a going concern basis, which assumes that the entity will be able to meet its financial obligations as at when they fall due. There are no significant financial obligations that will impact on the entity's resources which will affect the going concern of the entity. Management is satisfied that the entity has adequate resources to continue in operational existence for the foreseeable future. For this reason, the going concern basis has been adopted in preparing these consolidated financial statements.
Basis of measurement
These consolidated financial statements have been prepared in accordance with the going concern principle under the historical cost convention, except for financial assets (liabilities) which were measured at fair value. The liability for defined benefit obligations is recognized as the present value of the defined benefit obligation less the total of the plan assets, plus unrecognized actuarial gains, less unrecognized past service cost and unrecognized actuarial losses while the plan assets for defined benefit obligations are measured at fair value.
These consolidated financial statements are presented in the Nigerian Naira (NGN), which is the Company's functional currency for presentation.
Functional and presentation currency
Items included in these consolidated financial statements are measured using the currency of the primary economic environment in which the Group operates ("the functional currency"). The consolidated financial statements are presented in Nigerian Naira (N) which is the Group's functional currency and presentation currency.
Use of estimates and judgements
The preparation of these consolidated financial statements in conformity with IFRS requires the use of certain critical accounting estimates, it also requires management to exercise its judgment in the process of applying the company's accounting policies. Changes in assumptions may have a significant impact on these consolidated financial statements in the period the assumptions changed. Management believes that the underlying assumptions are appropriate and therefore the Group's financial statements present the financial position and results fairly.
Summary of Standards and Interpretations effective for the first time
IFRIC 23 Uncertainty over Income Tax Treatments
The interpretation specifies how an entity should reflect the effects of uncertainties in accounting for income taxes.
Standards Issued and Effective on or after 1 January 2024
IFRS 17 Insurance Contracts
IFRS 17 creates one accounting model for all insurance contracts in all jurisdictions that apply IFRS. This standard replaces IFRS 4 - Insurance contracts.
The key principles in IFRS 17 are that an entity:
identifies as insurance contracts those contracts under which the entity accepts significant insurance risk from another party (the policyholder) by agreeing to compensate the policyholder if a specified uncertain, future event (the insured event) adversely affects the policyholder;
separates specified embedded derivatives, distinct investment components and distinct performance obligations from the insurance contracts;
divides the contracts into groups it will recognise and measure;
recognises and measures groups of insurance contracts at a risk-adjusted present value of the future cash flows (the fulfilment cash flows) that incorporates all the available information about the fulfilment cash flows in a way that is consistent with observable market information plus (if this value is a liability) or minus (if this value is an asset) an amount representing the unearned profit in the group of contracts (the contractual service margin);
recognises the profit from a group of insurance contracts over the period the entity provides insurance coverage, and as the entity is released from risk, if a group of contracts is or becomes loss-making, an entity recognises the loss immediately;
presents separately insurance revenue, insurance service expenses and insurance finance income or expenses;
discloses information to enable users of financial statements to assess the effect that contracts within the scope of IFRS 17 have on the financial position, financial performance and cash flows of the entity. To do this, an entity discloses qualitative and quantitative information about:
the amounts recognised in its financial statements from insurance contracts;
the significant judgements, and changes in those judgements, made when applying the Standard; and
the nature and extent of the risks from contracts within the scope of this Standard.
2.2.2 IFRS 18 Presentation and Disclosure in Financial Statement Effective for on or after 1
January 2027.
IFRS 18 introduces newly defined 'operating profit' and 'profit or loss before financing and income tax'
Under IFRS 18, companies are no longer permitted to disclose operating expenses only in the notes.
nature
function; or
using a mixed presentation
If any operating expenses are presented by function, then new disclosures apply.
IFRS 18 also requires some 'non-GAAP' measures to be reported in the financial statements. It
a subtotal of income and expenses;
used in public communications outside the financial statements; and
reflective of management's view of financial performance.
For each MPM presented, companies need to explain in a single note to the financial statements why
2.2.3 IFRS 19 Subsidiaries without Public Accountability Disclosures effective 1 January 2027
IFRS 19 allows eligible subsidiaries to apply IFRS Accounting Standards with the reduced disclosure
it does not have public accountability
its parent produces consolidated financial statements under IFRS Accounting Standards available for A subsidiary applying IFRS 19 is required to clearly state in its explicit and unreserved statement of
Narrow Scope Amendments deferred until further notice
IFRS 10 consolidated financial statements
Sale or Contribution of Assets between an Investor and its Associate or Joint Venture (Amendments to IFRS 10 and IAS 28): Narrow scope amendment address an acknowledged inconsistency between the requirements in IFRS 10 and those in IAS 28 (2011), in dealing with the sale or contribution of assets between an investor and its associate or joint venture.
IAS 28 Investments in Associates and Joint Ventures
Sale or Contribution of Assets between an Investor and its Associate or Joint Venture (Amendments to IFRS 10 and IAS 28): Narrow scope amendment to address an acknowledged inconsistency between the requirements in IFRS 10 and those in IAS 28 (2011), in dealing with the sale or contribution of assets between an investor and its associate or joint venture.
New standards, amendments and interpretations issued but without an effective date
At the date of authorisation of these financial statements the following standards, amendments to
Amendments to IFRS 10 and IAS 28 consolidated financial statements and Investments in
Amends IFRS 10 consolidated financial statements and IAS 28 Investments in Associates and Joint
Require full recognition in the investor's financial statements of gains and losses arising on the
Require the partial recognition of gains and losses where the assets do not constitute a
These requirements apply regardless of the legal form of the transaction, e.g. whether the sale or
Significant accounting policies
The principal accounting policies adopted are set out below.
Foreign currency translation
Foreign currency transactions are booked in the functional currency of the Group (naira) at the exchange rate ruling on the date of transaction. Foreign currency monetary assets and liabilities are retranslated into the functional currency at rates of exchange ruling at the reporting period. Exchange differences are included in the Statement of profit or loss and other comprehensive income. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rates prevailing at the date when the fair value was determined. Non-monetary items that are measured in terms of historical cost in a foreign currency are not retranslated.
Basis of consolidation
The consolidated financial statements incorporate the financial statements of the Company and entities controlled by the Company (its subsidiaries) made up to 31 December each year. Control is achieved where the Company has the power to govern the financial and operating policies of an investee entity so as to obtain benefits from its activities.
The results of subsidiary acquired or disposed of during the year are included in the consolidated income statement from the effective date of acquisition or up to the effective date of disposal, as appropriate.
Where necessary, adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by the group. All intra-group transactions, balances, income and expenses are eliminated on consolidation.
Business combinations
Acquisitions of subsidiaries are accounted for using the acquisition method. The consideration for each acquisition is measured at the aggregate of the fair values (at the date of exchange) of assets given, liabilities incurred or assumed, and equity instruments issued by the Group in exchange for control of the acquire. Acquisition-related costs are recognised in profit or loss as incurred.
Where a business combination is achieved in stages, the Group's previously-held interests in the acquired entity are re-measured to fair value at the acquisition date (i.e. the date the Group attains control) and the resulting gain or loss, if any, is recognised in profit or loss. Amounts arising from
interests in the acquiree prior to the acquisition date that have previously been recognised in other comprehensive income are reclassified to profit or loss, where such treatment would be appropriate if that interest were disposed of.
The acquiree's identifiable assets, liabilities and contingent liabilities that meet the conditions for recognition under IFRS 3(2008) are recognised at their fair value at the acquisition date, except that:
Deferred tax assets or liabilities and liabilities or assets related to employee benefit arrangements are recognised and measured in accordance with IAS 12 Income Taxes and IAS 19 Employee Benefits respectively;
assets (or disposal groups) that are classified as held for sale in accordance with IFRS 5 Noncurrent Assets Held for Sale and Discontinued Operations are measured in accordance with that Standard.
If the initial accounting for a business combination is incomplete by the end of the reporting period in which the combination occurs, the Group reports provisional amounts for the items for which the accounting is incomplete. Those provisional amounts are adjusted during the measurement period (see below), or additional assets or liabilities are recognised, to reflect new information obtained about facts and circumstances that existed as of the acquisition date that, if known, would have affected the amounts recognised as of that date.
The measurement period is the period from the date of acquisition to the date the Group obtains complete information about facts and circumstances that existed as of the acquisition date, and is subject to a maximum of one year.
Revenue recognition
Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances.
Sale of goods
Revenue from the sale of goods is recognised when the goods are delivered and titles have passed, at which time all the following conditions are satisfied:
the Group has transferred to the buyer the significant risks and rewards of ownership of the
the Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;
the amount of revenue can be measured reliably;
it is probable that the economic benefits associated with the transaction will flow to the Group;
the costs incurred or to be incurred in respect of the transaction can be measured reliably;
the Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold.
Interest income
Interest income from a financial asset is recognised when it is probable that the economic benefits will flow to the Group and the amount of income can be measured reliably. Interest income is accrued on a time basis, by reference to the principal outstanding and at the effective interest rate applicable, which is the rate that exactly discounts estimated future cash receipts through the expected life of the financial asset to that asset's net carrying amount on initial recognition.
Expenditure
Expenditure is recognised in respect of goods and services received when supplied in accordance with contractual terms. Provision is made when an obligation exists for a future liability in respect of a past event and where the amount of the obligation can be reliably estimated. Manufacturing start-up costs between validation and the achievement of normal production are expensed as incurred. Advertising and promotion expenditure is charged to profit or loss as incurred. Shipment costs on inter company transfers are charged to cost of sales; distribution costs on sales to customers are included in distribution expenditure. Restructuring costs are recognised and provided for, where appropriate, in respect of the direct expenditure of a business reorganisation where the plans are sufficiently detailed and well advanced, and where appropriate communication to those affected has been undertaken.
Intangible assets
Intangible assets acquired separately
Intangible assets with finite useful lives that are acquired separately are carried at cost less accumulated amortisation and accumulated impairment losses. Amortisation is recognised on a straight-line basis over their estimated useful lives. The estimated useful life and amortisation method are reviewed at the end of each reporting period, with the effect of any changes in estimate being accounted for on a prospective basis. Intangible assets with indefinite useful lives that are acquired separately are carried at cost less accumulated impairment losses.
Internally generated intangible assets - research and development expenditure
Expenditure on research activities is recognised as an expense in the period in which it is incurred An internally-generated intangible asset arising from development (or from the development phase of an internal project) is recognised if, and only if, all of the following have been demonstrated:
the technical feasibility of completing the intangible asset so that it will be available for use or sal
the intention to complete the intangible asset and use or sell it;
the ability to use or sell the intangible asset;
how the intangible asset will generate probable future economic benefits;
the availability of adequate technical, financial and other resources to complete the development and to use or sell the intangible asset; and
the ability to measure reliably the expenditure attributable to the intangible asset during its development.
The amount initially recognised for internally-generated intangible assets is the sum of the expenditure incurred from the date when the intangible asset first meets the recognition criteria listed above. Where no internally-generated intangible asset can be recognised, development expenditure is recognised in profit or loss in the period in which it is incurred.
Subsequent to initial recognition, internally-generated intangible assets are reported at cost less accumulated amortisation and accumulated impairment losses, on the same basis as intangible assets that are acquired separately.
Intangible assets acquired in a business combination and recognised separately from goodwill are initially recognised at their fair value at the acquisition date (which is regarded as their cost).
Subsequent to initial recognition, intangible assets acquired in a business combination are reported at cost less accumulated amortisation and accumulated impairment losses, on the same basis as intangible assets that are acquired separately.
An intangible asset is derecognised on disposal, or when no future economic benefits are expected from use or disposal. Gains or losses arising from derecognition of an intangible asset, measured as the difference between the net disposal proceeds and the carrying amount of the asset, are recognised in profit or loss when the asset is derecognised.
Legal and other dispute
Provision is made for the anticipated settlement costs of legal or other disputes against the Group where an outflow of resources is considered probable and a reliable estimate can be made of the likely outcome. In addition, provision is made for legal or other expenses arising from claims received or other disputes. In respect of product liability claims related to certain products, there is sufficient history of claims made and settlements to enable management to make a reliable estimate of the provision required to cover un-asserted claims. The Group may become involved in legal proceedings, in respect of which it is not possible to make a reliable estimate of the expected financial effect, if any, that could result from ultimate resolution of the proceedings. In these cases, appropriate disclosure about such cases would be included but no provision would be made. Costs associated with claims made by the Group against third parties are charged to profit or loss as they are incurred. When the group is virtually certain of receiving reimbursement from a third party (in the form of insurance, a shared liability agreement etc.) to compensate for any lost financial benefit from such disputes, they should recognise a receivable as an asset.
Pensions and other post-employment benefits Defined contribution scheme
The Group operates a defined contribution based retirement benefit scheme for its staff, In accordance with the provisions of the amended Pension Reform Act, 2014 the Company has instituted a Contributory Pension Scheme for its employees, where both the employees and the company contribute 7% and 11% of the employee total emoluments. The company's contribution under the scheme is charged to the profit and loss while employee contributions are funded through payroll deductions.
In addition to the pension scheme, the Company operates a gratuity scheme payable to employees that have served a minimum of five years of service. The benefits are calculated based on employees salary for each qualifying year. The Company discharges its obligation to employees once payment is made to the fund managers.
Property plant and equipment
Property, plant and equipment is carried in the consolidated statement of financial position at cost less accumulated depreciation and accumulated impairment.
The cost of acquisition comprises the acquisition price plus ancillary and subsequent acquisition costs, less any reduction received on the acquisition price. The cost of self-constructed property, plant and equipment comprises the direct cost of materials, direct manufacturing expenses, and appropriate allocations of material and manufacturing overheads. Where an obligation exists to dismantle or remove an asset or restore a site to its former condition at the end of its useful life, the present value of the related future payments is capitalized along with the cost of acquisition or construction upon completion and a corresponding liability is recognized.
If the construction phase of property, plant or equipment extends over a long period, the interest incurred on borrowed capital up to the date of completion is capitalized as part of the cost of acquisition or construction in accordance with IAS 23 (Borrowing Costs).
Expenses for the repair of property, plant and equipment, such as on-going maintenance costs, are normally recognized in profit or loss. The cost of acquisition or construction is capitalized if a repair (such as a complete overhaul of technical equipment) will result in future economic benefits.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives, using the straight-line method. Freehold land is not depreciated. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis.
The following depreciation periods, based on the estimated useful lives of the respective assets, are applied throughout the Group:
Class Useful life (range)
Buildings 50 years
Plant, machinery and fittings 5 - 10 years
Office equipment and furniture 4 - 10 years
Trucks and motor vehicles 3 - 8 years
An item of property, plant and equipment is derecognised upon disposal or when no future economic benefits are expected to arise from the continued use of the asset. Any gain or loss arising on the disposal or retirement of an item of property, plant and equipment is determined as the difference between the sales proceeds and the carrying amount of the asset and is recognised in profit or loss.
Financial instruments
Classification and measurement of financial assets
Financial assets, which include both debt and equity securities are measured at initial recognition at fair value, and are classified and subsequently measured at fair value through profit or loss (FVTPL), fair value through other comprehensive income (FVOCI) or amortised cost. Subsequent classification and measurement for debt securities is based on our business model for managing the financial instruments and the contractual cash flow characteristics of the instruments.
Debt instruments are measured at amortised cost if both of the following conditions are met and the
Business model assessment
The Group determines the business models at the level that best reflects how portfolios of financial assets are managed to achieve the its business objectives. Judgment is used in determining the business models, which is supported by relevant, objective evidence including:
How the economic activities of the group's businesses generate benefits and how such economic activities are evaluated and reported to key management personnel;
The significant risks affecting the performance of the group's businesses, for example, market risk, credit risk, or other risks and the activities undertaken to manage those risks; and
Historical and future expectations of sales of the loans or securities portfolios managed as part of a business model.
The Group's business models fall into three categories, which are indicative of the key strategies used to generate returns:
Hold-to-Collect (HTC): The objective of this business model is to hold loans and securities to collect contractual principal and interest cash flows. Sales are incidental to this objective and are expected to be insignificant or infrequent.
Hold-to-Collect-and-Sell (HTC&S): Both collecting contractual cash flows and sales are integral to achieving the objective of the business model.
Other fair value business models: These business models are neither HTC nor HTC&S, and primarily represent business models where assets are held-for-trading or managed on a fair value basis.
SPPI assessment
Instruments held within a HTC or HTC&S business model are assessed to evaluate if their contractual cash flows are comprised of solely payments of principal and interest. SPPI payments are those which would typically be expected from basic lending arrangements. Principal amounts include par repayments from lending and financing arrangements, and interest primarily relates to basic lending returns, including compensation for credit risk and the time value of money associated with the principal amount outstanding over a period of time.
Interest can also include other basic lending risks and costs (for example, liquidity risk, servicing or administrative costs) associated with holding the financial asset for a period of time, and a profit margin.
Where the contractual terms introduce exposure to risk or variability of cash flows that are inconsistent with a basic lending arrangement, the related financial asset is classified and measured at FVTPL.
e. Investment securities
All investment securities are initially recorded at fair value and subsequently measured according to the respective classification. Prior to our adoption of IFRS 9, Investment securities were comprised of available-for sale securities and held-for-trading securities.
Financial liabilities
Initial recognition and measurements
Financial liabilities are classified, at initial recognition, as financial liabilities at fair value through profit or loss, loans and borrowings, payables, or as derivatives designated as hedging instruments in an effective hedge, as appropriate.
All financial liabilities are recognised initially at fair value and, in the case of loans and borrowings and payables, net of directly attributable transaction costs.
The Company's financial liabilities include trade and other payables, loans and borrowings including bank overdrafts.
Cash and cash equivalents
Cash and cash equivalents comprise cash and short-term, highly liquid investments that are readily convertible into known amounts of cash and which are subject to an insignificant risk of changes in value. An investment with a maturity of three months or less is normally classified as being short-term. Cash and cash equivalents form part of the company's financial assets.
Trade and other receivables
Trade receivables are stated at fair value and subsequently measured at fair value through profit or loss, less provision for impairment. Impairment thereon are computed using the simplified IFRS 9
Trade and other payables
Trade and other payables are stated at their original invoiced value. The Directors consider the carrying amount of other payables to approximate their fair value.
Impairment of financial assets
Financial assets are assessed for indicators of impairment at the end of each reporting period. Financial assets are considered to be impaired when there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows of the investment have been affected.
For AFS equity investments, a significant or prolonged decline in the fair value of the security below its cost is considered to be objective evidence of impairment.
For all other financial assets, objective evidence of impairment could include:
significant financial difficulty of the issuer or counterparty; or
breach of contract, such as a default or delinquency in interest or principal payments; or
it becoming probable that the borrower will enter bankruptcy or financial re-organisation; or
the disappearance of an active market for that financial asset because of financial difficulties.
For certain categories of financial assets, such as trade receivables, assets that are assessed not to be impaired individually are, in addition, assessed for impairment on a collective basis. Objective evidence of impairment for a portfolio of receivables could include the Group's past experience of collecting payments, an increase in the number of delayed payments in the portfolio past the average credit period of 30 days, as well as observable changes in national or local economic conditions that correlate with default on receivables.
For financial assets carried at amortised cost, the amount of the impairment loss recognised is the difference between the asset's carrying amount and the present value of estimated future cash flows, discounted at the financial asset's original effective interest rate.
For financial assets carried at cost, the amount of the impairment loss is measured as the difference between the asset's carrying amount and the present value of the estimated future cash flows discounted at the current market rate of return for a similar financial asset. Such impairment loss will not be reversed in subsequent periods.
The carrying amount of the financial asset is reduced by the impairment loss directly for all financial assets with the exception of trade receivables, where the carrying amount is reduced through the use of an allowance account. When a trade receivable is considered uncollectible, it is written off against the allowance account. Subsequent recoveries of amounts previously written off are credited against the allowance account. Changes in the carrying amount of the allowance account are recognised in profit or loss.
When an AFS financial asset is considered to be impaired, cumulative gains or losses previously recognised in other comprehensive income are reclassified to profit or loss in the period.
For financial assets measured at amortised cost, if, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognised, the previously recognised impairment loss is reversed through profit or loss to the extent that the carrying amount of the investment at the date the impairment is reversed does not exceed what the amortised cost would have been had the impairment not been recognised.
In respect of AFS equity securities, impairment losses previously recognised in profit or loss are not reversed through profit or loss. Any increase in fair value subsequent to an impairment loss is recognised in other comprehensive income and accumulated under the heading of investments revaluation reserve. In respect of AFS debt securities, impairment losses are subsequently reversed through profit or loss if an increase in the fair value of the investment can be objectively related to an event occurring after the recognition of the impairment loss.
Derecognition of financial assets
The Group derecognises a financial asset only when the contractual rights to the cash flows from the asset expire, or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another entity. If the Group neither transfers nor retains substantially all the risks and rewards of ownership and continues to control the transferred asset, the Group recognises its retained interest in the asset and an associated liability for amounts it may have to pay. If the Group retains substantially all the risks and rewards of ownership of a transferred financial asset, the Group continues to recognise the financial asset and also recognises a collateralised borrowing for the proceeds received.
On derecognition of a financial asset in its entirety, the difference between the asset's carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss that had been recognised in other comprehensive income and accumulated in equity is recognised in profit or loss.
On derecognition of a financial asset other than in its entirety (e.g. when the Group retains an option to repurchase part of a transferred asset), the Group allocates the previous carrying amount of the financial asset between the part it continues to recognise under continuing involvement, and the part it no longer recognises on the basis of the relative fair values of those parts on the date of the transfer. The difference between the carrying amount allocated to the part that is no longer recognised and the sum of the consideration received for the part no longer recognised and any cumulative gain or loss allocated to it that had been recognised in other comprehensive income is recognised in profit or loss. A cumulative gain or loss that had been recognised in other comprehensive income is allocated between the part that continues to be recognised and the part that is no longer recognised on the basis of the relative fair values of those parts.
Financial liabilities
Financial liabilities are recognised when the Group becomes party to the contractual provisions of an instrument and are initially recognised at fair value adding transaction costs.
Financial liabilities ( including borrowings and trade payables) are subsequently measured at amortised cost using the effective interest method.
The effective interest method is a method of calculating the amortised cost of a financial liability and of allocating interest expense over the relevant period. The effective interest rate is the rate that exactly discounts estimated future cash payments (including all fees and points paid or received that form an integral part of the effective interest rate, transaction costs and other premiums or discounts) through the expected life of the financial liability, or (where appropriate) a shorter period, to the net carrying amount on initial recognition.
Financial liabilities (continued)
The Group derecognises financial liabilities when, and only when, the Group's obligations are discharged, cancelled or they expire. The difference between the carrying amount of the financial liability derecognised and the consideration paid and payable is recognised in profit or loss.
Other receivables and liabilities
Accrued items and other non-financial assets and liabilities are carried at cost. They are charged/credited to profit or loss according to performance of the underlying transaction.
Government grants
Government grants are not recognised until there is reasonable assurance that the Group will comply with the conditions attaching to them and that the grants will be received. The benefit of a government loan at a below-market rate of interest is treated as a government grant, measured as the difference between proceeds received and the fair value of the loan based on prevailing market interest rates. Government grants relating to property, plant and equipment are treated as deferred revenue and released to profit or loss over the expected useful lives of the assets concerned.
Inventories
In accordance with IAS 2 (Inventories), inventories encompass assets held for sale in the ordinary course of business (finished goods and goods purchased for resale), in the process of production for such sale (work in process) or in the form of materials or supplies to be consumed in the production process or in the rendering of services (raw materials and supplies). Inventories are stated at the lower of cost and net realizable value. The net realizable value is the achievable sale proceeds under normal business conditions less estimated cost to complete and selling expenses. Costs of inventories are determined on a first-in-first-out basis.
Taxation
Income tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from profit as reported in the consolidated statement of profit or loss and other comprehensive income because of items of income or expense that are taxable or deductible in other years and items that are never taxable or deductible. The Group's liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the end of the reporting period.
Deferred tax
Deferred tax is recognised on temporary differences between the carrying amounts of assets and liabilities in the consolidated financial statements and the corresponding tax bases used in the computation of taxable profit. Deferred tax liabilities are generally recognised for all taxable temporary differences. Deferred tax assets are generally recognised for all deductible temporary differences to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilised. Such deferred tax assets and liabilities are not recognised if the temporary difference arises from goodwill or from the initial recognition (other han in a business combination) of other assets and liabilities in a transaction that affects neither the taxable profit nor the accounting profit. For any temporary differences arising on business combinations where the Group can control the reversal of the temporary difference and it is not expected to reverse in the near future, the deferred tax aset/liability is not recognised.
The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liability is settled or the asset realised, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Group expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.
Current and deferred tax for the year
Current and deferred tax are recognised in profit or loss, except when they relate to items that are recognised in other comprehensive income or directly in equity, in which case, the current and deferred tax are also recognised in other comprehensive income or directly in equity respectively. Where current tax or deferred tax arises from the initial accounting for a business combination, the tax effect is included in the accounting for the business combination.
Discounting
Where the effect of the time value of money is material, balances are discounted to present values using appropriate rates of interest. The unwinding of the discounts is recorded in finance income and finance costs.
Noncurrent asset held for sale
Non-current assets are classified as assets held for sale and stated at the lower of their previous carrying amount and fair value less costs to sell if their carrying value is to be recovered principally through a sale transaction rather than through continuing use. The condition of being recovered through sale is only met when: "the sale is highly probable, the non-current asset is available for immediate sale in its present condition, management is committed to the sale and the sale is expected to qualify for recognition as a completed sale within one year from the date of classification."
Borrowing costs
Borrowing costs directly attributable to the acquisition, construction or production of qualifying assets, which are assets that necessarily take a substantial period of time to get ready for their intended use or sale, are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale. Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalisation. All other borrowing costs are recognised in profit or loss in the period in which they are incurred.
Dividends
Dividends are recognised as a liability in the financial statement in the year in which the dividend is approved by the shareholders.
Segment reporting
Operating segments are reported in a manner consistent with the internal reporting provided to the chief operating decision maker. The chief operating decision maker, who is responsible for allocating resources and assessing performance of the operating segments, has been identified as the Chief Executive Officer.
Earnings per share
Earnings per share are calculated by dividing profit for the year by the number of ordinary shares outstanding during the period. Diluted earnings per share are calculated by dividing profit for the year by the fully-diluted number of ordinary shares outstanding during the period.
Critical accounting judgements and key sources of estimation uncertainty
In the application of the Group's accounting policies, which are described in note 3, the directors are required to make judgements, estimates and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.
The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised if the revision affects only that period, or in the period of the revision and future periods if the revision affects both current and future periods.
Critical accounting judgement
The following are the critical judgements and estimates that the directors have made in the process of applying the Company's accounting policies and that have the most significant effect on the amounts recognised in financial statements.
Revenue recognition
In the application of the Group's policy that states that revenues are recognized when significant risks and rewards has been transferred to the buyer, Management has ensured that revenues are recognised when goods are delivered to Customers. When goods remain in the Company's facility as a result of delayed transportation arrangement by the Customer, the Customers are aware based on practice and signed contract notes that the risks and reward of such goods remain with them.
Indefinite useful life of Intangible assets
During the year, the directors reconsidered the recoverability of the Group's intangible asset ( trade mark) and assessed if the useful life is still indefinite,the trademark conveys an irrevocable right of use to the Company. Management's assessment for recoverability includes active sales from the products, competition and current market share of the products, it is believed that the asset is fully recoverable.
Key sources of estimation uncertainty
The following are the key assumptions concerning the future, and other key sources of estimation uncertainty at the end of the reporting period, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year.
Useful life of Property, Plant and Equipment
Property plant and equipment represent the most significant proportion of the asset base of the Company, accounting for over 60 % of the Company's total assets. Therefore the estimates and assumptions made to determine their carrying value and related depreciation are critical to the Company's financial position and performance and have been properly done.
The charge in respect of periodic depreciation is derived after determining an estimate of an asset's expected useful life and the expected residual value at the end of its life. Increasing an asset's expected life or it's residual value would result in the reduced depreciation charge in the profit or loss.
The useful lives and residual values of the of property, plant and equipment are determined by management.
Allowance for doubtful receivables
Judgment is exercised to make allowance for trade receivables doubtful of recovery by reference to the financial and other circumstances of the debtor in question. Based on the credit terms and experience regarding trade receivables, the Company makes full impairment allowance for doubtful debt of over 360 days
Allowance for obsolete inventory
Management continously assesses inventory items for obsolescence based on the standard operating practice of the Company.
Fair valuation of loan
To obtain the fair value of a loan obtained at below market interest rate, the Group used a valuation technique that include inputs that are based on observable market data Management believes that the key assumptions used in the determination of the fair value are appropriate.
The Group
September December September
2025 2024 2024
The Company
September December
2025 2024
September
2024
N'000 N'000 N'000 N'000 N'000 N'000
Revenue
An analysis of the Group's revenue is as follows:
Sale of Goods
29,525,378 28,905,152 21,821,614
26,775,789
26,492,521
19,876,592
Total revenue
29,525,378 28,905,152 21,821,614
26,775,789
26,492,521
19,876,592
Segment information
Information reported to the chief operating decision maker for the purposes of resource allocation and assessment of segment performance focuses on both the types of goods or services delivered or provided and the market where the goods or services are delivered or provided. The Group's
reportable segments under IFRS 8 are therefore as follows.
Pharmeceuticals - This segment is involved in the production and sale of human pharmaceuticals and human vaccines.
Beverage - This segment is involved in the production of beverage drinks including bottled water.
The Group
September December September
2025 2024 2024
The Company
September December
2025 2024
September
2024
N'000 N'000 N'000 N'000 N'000 N'000
Segment revenue
29,185,741 28,704,316 21,683,446 | 26,436,152 | 26,291,685 | 19,738,424 | |
339,636 200,836 138,168 | 339,636 | 200,836 | 138,168 | |
29,525,378 28,905,152 21,821,614 | 26,775,789 | 26,492,521 | 19,876,592 |
Pharmaceuticals Beverage
Segment revenue reported above represents revenue generated from external customers. There were no inter-segment sales in the current year.
The Gr September | oup December | September | The C September | om | pany December | September | |
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
6.2 Segment Profit | |||||||
Pharmaceuticals | 10,053,211 | 8,490,100 | 6,738,184 | 9,037,379 | 7,593,179 | 5,990,901 | |
Beverage | 59,110 | 23,353 | 21,396 | 59,110 | 23,353 | 21,396 | |
Total segment Gross profit | 10,112,321 | 8,513,453 | 6,759,580 | 9,096,489 | 7,616,532 | 6,012,297 | |
Other operating income (Note 7) | (17,790) | 146,099 | (106,191) | (41,821) | 108,293 | (127,080) | |
Interest Income (Note 8) | 412,840 | 407,490 | 255,790 | 397,598 | 367214 | 227,354 | |
Selling, marketing, Distribution and Admin costs | (5,015,640) | (6,096,898) | (3,763,618) | (4,675,904) | (5,556,950) | (3,466,687) | |
Finance costs | (541,651) | (370,115) | (360,702) | (507,536) | (370,115) | (296,724) | |
Share of (loss)/profit from joint venture | (34,946) | (27,187) | (8,578) | - | - | - | |
Profit before tax | 4,915,135 | 2,572,842 | 2,776,280 | 4,268,827 | 2,164,974 | 2,349,159 |
Segment accounting policies
The accounting policies of the reportable segments are the same as the Group's accounting policies described in note 3. Segment profit represents the gross profit earned by each segment without allocation of central administration costs and directors' salaries, selling, marketing and distribution expenses, other operating income, finance costs and income tax expense. This is the measure reported to the chief operating decision maker for the purposes of resource allocation and assessment of segment performance.
Segment assets and liabilities
The Chief Executive Officer does not assess segment performance based on reports on segment assets and liabilities.
Information about major customers
There are no customers that represent more than 10% of the total revenue of any of the reported segments.
Geographical information
The Group operates in Lagos and West, East and North principal geographical areas. The Group's revenue from continuing operations from external customers by location of operations are as follows:
The Group Revenue from Revenue from Revenue | The Company Revenue Revenue from Revenue from | |||||||
External | External | from | from External | External | External | |||
Customers | Customers | External Customers | Customers | Customers | Customers | |||
September | December | September | September | December | September | |||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |||
East | 9,583,586 | 9,438,569 | 7,212,999 | 8,580,450 | 8,718,922 | 6,640,331 | ||
West | 6,763,232 | 6,158,298 | 4,587,609 | 6,251,173 | 5,812,454 | 4,317,381 | ||
Lagos | 9,519,901 | 9,457,562 | 7,375,446 | 8,543,112 | 8,333,855 | 6,436,489 | ||
North | 3,658,659 3,850,722 2,645,560 | 3,401,054 3,627,290 2,482,391 | ||||||
Total | 29,525,377 | 28,905,152 | 21,821,614 | 26,775,789 | 26,492,521 | 19,876,592 | ||
The Group | The Company | |||||||
September | December | September | September | December | September | |||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |||
7. | Other operating income Income on contract manufacturing | 28,488 | 84,936 | 3,575 | 28,488 | 84,899 | 3,575 | |
Miscelaneous Income (Note 7.1) | 54,112 | 4,247 | 66,641 | 52,649 | 4,247 | 66,605 | ||
Rental Income | 11,250 | 18,000 | 14,250 | 11,250 | 18,000 | 14,250 | ||
Exchange gain/(Loss) | (115,006) | 36,783 | (192,789) | (138,614) | - | (212,657) | ||
Profit/(loss) on disposal of PPE ( Note 7.2) | 3,366 | 2,133 | 2,132 | 4,406 | 1,147 | 1,147 | ||
(17,790) | 146,099 | (106,191) | (41,821) | 108,293 | (127,080) | |||
Miscelaneous Income
Miscelaneous income represents insurance premiums received from various insurance companies and sales of scraps
Profit/Loss on disposal of PPE
This includes profit made from the sales of old vehicles,laptops and other non-critical PPEs
September | The Group December | September | September | The Company December | September | |||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |||
8. | Interest Income | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |
Bank interest | 412,840 | 407,491 | 255,790 | 397,598 | 375,834 | 227,354 | ||
412,840 | 407,491 | 255,790 | 397,598 | 375,834 | 227,354 |
The interest income is earned on short term investments (fixed deposits) with various commercial banks and fund managers in Nigeria. The investments are not designated at fair value through profit or loss, rather they are carried at amortised cost.
10. Finance cost
Interest on bank loans and overdrafts
692,874
514,879
469,859
658,759
405,789
405,881
Deffered Income realised
(151,223)
(144,764)
(109,157)
(151,223)
(151,715)
(109,157)
Net Finance cost
541,651
370,115
360,702
507,536
254,074
296,724
11. Profit for the year is attributed to:
Owners of the bussiness
3,342,292
1,620,966
1,887,871
2,902,802
1,361,255
1,597,428
3,342,292
1,620,966
1,887,871
2,902,802
1,361,255
1,597,428
All the profit of the Group is attributable to Owners of the company as there are no non-controlling interests.
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30th September, 2025.
The Group
September December September 2025 2024 2024
Number Number Number
The Company
September December September 2025 2024 2024
Number Number Number
12a Employees remunerated at higher rates
The number of employees excluding Directors in respect of emoluments excluding provident fund contributions and allowances:
N | N | ||||||||||
100,000 | 200,000 | 0 | 1 | 1 | 0 | 1 | 1 | ||||
250,001 | - 300,000 | 1 | 0 | - | 1 | 0 | - | ||||
300,001 | - 350,000 | - | 0 | - | - | 0 | - | ||||
350,001 | - 400,000 | - | 0 | - | - | 0 | - | ||||
400,001 | - 450,000 | 40 | 42 | 41 | 40 | 42 | 41 | ||||
450,001 | - 500,000 | 23 | 24 | 24 | 23 | 24 | 24 | ||||
500,001 | - 550,000 | 10 | 10 | 10 | 10 | 10 | 10 | ||||
550,001 | - 600,000 | - | 0 | - | - | 0 | - | ||||
600,001 | - 650,000 | - | 0 | - | - | 0 | - | ||||
650,001 - 700,000 30 | 26 | 20 | 23 | 18 | 12 | ||||||
700,001 and above 293 | 293 | 292 | 270 | 270 | 270 | ||||||
- 397 | 396 | 388 | 367 | 365 | 358 | ||||||
The average number of persons employed in the financial | |||||||||||
year are as follows: | |||||||||||
Managerial | 22 | 22 | 23 | 22 | 22 | 23 | |||||
Senior staff | 211 | 213 | 206 | 181 | 182 | 176 | |||||
Junior staff | 164 | 161 | 159 | 164 | 161 | 159 | |||||
397 | 396 | 388 | 367 | 365 | 358 | ||||||
13. Taxation | N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |
13.1 Current tax liabilities At 1 January | 805,841 | 299,043 | 299,042 | 651,520 | 225,769 | 225,769 | |
Charge for the year (see note below) | 1,572,843 | 786,500 | 888,410 | 1,366,025 | 636,338 | 751,731 | |
2,378,684 | 1,085,544 | 1,187,452 | 2,017,545 | 862,107 | 977,500 | ||
Payment during the year | (788,435) | (279,703) | (282,141) | (634,933) | (210,587) | (209,587) | |
Closing Balance | 1,590,248 | 805,841 | 905,311 | 1,382,612 | 651,520 | 767,913 |
The charge for taxation in these financial statements was based on the provisions of the Companies Income Tax Act, CAP C21, LFN 2004 as amended, the Education Tax Act, CAPE 4, LFN 2004 and Finance Act 2020.
September | The Group December | September | September | The Company December | September | |||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |||
13.2 | Deferred taxation | |||||||
At 1 January | 1,148,418 | 986,482 | 986,486 | 1,139,069 | 971,688 | 971,688 | ||
Adjustment to opening bal | 3 | - | ||||||
Charge for the year | - | 161,936 | - | - | 167,381 | - | ||
As At 30th September | 1,148,421 | 1,148,418 | 986,486 | 1,139,069 | 1,139,069 | 971,688 | ||
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30th September, 2025.
September | The Group December | September | September | The Company December | September | ||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
14. Earnings per share | |||||||
The earnings and weighted average number of ordinary | |||||||
shares used in the calculation of basic and diluted | |||||||
earnings per share are as follows. | |||||||
Earnings | |||||||
Earnings for the purpose of basic earnings per share | |||||||
being net profit attributable to equity holders of the Company | 3,342,292 | 1,620,966 | 1,887,871 | 2,902,802 | 1,361,255 | 1,597,428 | |
Number of shares | |||||||
Weighted average number of ordinary shares for the purpose of basic earnings per share | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | |
Earnings per 50k share (kobo) - basic | 193.73 | 93.96 | 109.43 | 168.26 | 78.90 | 92.59 | |
Weighted average number of ordinary shares for the purpose of dilutive earnings per share | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | 1,725,235 | |
Earnings per 50k share (kobo) - diluted | 193.73 | 93.96 | 109.43 | 168.26 | 78.90 | 92.59 | |
15. Intangible assets | |||||||
Software | 12,305 | 13,234 | 14,142 | 12,266 | 13,149 | 8,494 |
Software represents the cost of acquisition of HR software -Microsoft Office tools and other softwares. Management estimates that the benefit of this intangible will accrue over a period of five years .
MAY & BAKER NIGERIA PLC
NOTES TO THE UNAUDITED CONSOLIDATED FINANCIAL STATEMENTS FOR THE PERIOD ENDED 30th September, 2025.
Fixed asset schedule
GROUP - FIXED ASSETS SCHEDULE AT 30th September, 2025
LAND
Building
Plant & Machinery
TRUCK
Motor Vehicle
CUMPUTER/OFFI CE EQUPMENT
FACTORY EQUIPMENT
FURNITURE &FITTING
SUB TOTAL
Capital Work-In-Progress
TOTAL
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
Cost
At 1 January 2025
334,667
3,504,623
5,144,879
148,903
1,318,918
754,692
40,768
205,848
11,453,296
81,571
11,534,867
Additions
-
53,090
460,132
134,449.00
117,601
166,459
49,726.99
29,019.00
1,010,477
428,595
1,439,072
Disposals
-
-
(11,720.00)
-
(18,032)
(1,195)
-
(1,133)
(32,080)
-
(32,080)
Transfers from Capital WIP
-
-
(427,165)
(427,165)
At 30th September, 2025
334,667
3,557,713
5,616,731
283,352
1,454,551
922,346
90,495
236,000
12,431,693
83,001
12,514,695
Depreciation
At 1 January 2025
-
805,968
3,095,107
88,772
955,694
495,495
39,540
90,279
5,570,855
5,570,855
Charge for the year
49,656
222,073
19,526
201,361
91,646
908
11,935
597,105
597,105
Disposals
-
-
(3,724.00)
-
(18,031.00)
(1,084.00)
-
(1,123.00)
(23,962)
(23,962)
Transfers from Capital WIP
-
-
At 30th September, 2025
-
855,624
3,313,456
108,298
1,139,024
586,057
40,448
101,091
6,143,998
-
6,143,998
Net book value
At 30th September, 2025
334,667
2,702,089
2,303,275
175,054
315,527
336,288
50,047
134,909
6,287,695
83,001
6,370,697
COMPANY- FIXED ASSETS SCHEDULE AS AT 30th September, 2025 (0.99)
LAND
Building
Plant & Machinery
TRUCK
Motor Vehicle
CUMPUTER/OFFI CE EQUPMENT
FACTORY EQUIPMENT
FURNITURE &FITTING
SUB TOTAL
Capital Work-In-Progress
TOTAL
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
=N='000
Cost
At 1 January 2025
334,667
3,504,623
5,133,710
148,903
1,154,842
750,342
40,768
202,490
11,270,343
81,571
11,351,914
Additions
-
53,090
460,132
134,449.00
74,601
166,034
49,727
28,234
966,267
428,595
1,394,862
Transfers from Capital WIP
-
-
-
-
-
-
-
-
(427,165)
(427,165)
Disposals
-
(6,994)
-
(10,428)
(1,195)
-
(1,133)
(19,750)
-
(19,750)
At 30th September, 2025
334,667
3,557,713
5,586,848
283,352
1,219,015
915,181
90,495
229,591
12,216,860
83,001
12,299,862
Depreciation
At 1 January 2025
805,968
3,091,076
88,772
841,476
492,910
39,540
88,928
5,448,670
5,448,670
Charge for the year
49,656
221,270
19,526
175,338
91,027
908
11,613
569,338
569,338
Transfers from Capital WIP
-
-
-
-
-
-
-
-
Disposals
-
(1,120)
-
(10,427)
(1,084)
-
(1,123)
(13,754)
(13,754)
At 30th September, 2025
-
855,624
3,311,226
108,298
1,006,387
582,853
40,448
99,418
6,004,254
-
6,004,254
Net book value
At 30th September, 2025
334,667
2,702,089
2,275,622
175,054
212,628
332,327
50,047
130,173
6,212,606
83,001
6,295,608
26
The following depreciation rates were used in the computation of depreciation charge during the year:
Class Useful lives
Buildings 50years
Plant, machinery and fittings 5-10 years
Office equipment and furniture 4-10 years
Trucks and motor vehicles 3-8 years
Impairment of property, plant and equipment
There are no indicators of impairment at the end of the reporting period. Thus, the directors are of the opinion that allowance for impairment is not required.
September | The Group December | September | September | The Company December | September | |
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | |
16.4 Depreciation charged for the year is included in: | ||||||
Cost of sales | 291,507 | 351,791 | 265,343 | 291,507 | 351,791 | 257,690 |
Administrative expenses | 154,846 | 175,364 | 140,948 | 153,591 | 172,614 | 135,774 |
Distribution, sales and marketing expenses | 144,383 | 204,743 | 131,425 | 126,950 | 165,373 | 112,224 |
590,736 | 731,898 | 537,716 | 572,048 | 689,778 | 505,688 | |
17. Investment in Joint Venture | ||||||
Opening Balance | 1,171,368 | 1,198,555 | 1,198,555 | 1,326,886 | 1,326,886 | 1,326,886 |
Movement during the year-share of Profit/(loss) | (34,946) | (27,187) | (8,578) | - | - | - |
Transfer to investment in JV | - | - | - | - | - | - |
1,136,422 | 1,171,368 | 1,189,977 | 1,326,886 | 1,326,886 | 1,326,886 |
The Group | The Company | ||||||
September | December | September | September | December | September | ||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
18. | Investment in subsidiaries | ||||||
Carrying amount (at cost) | 3,000 | 3,000 | 3,000 | ||||
Name of subsidiary | Proportion of ownership | Place of incorporation | Principal activity | |
Osworth Nigeria Limited | 100% | Nigeria | Distribution and sales of healthcare pharamaceutical products. | and |
Tydipack Nigeria Limited | 100% | Nigeria | ||
Healthcare and industrial packaging | ||||
Servisure Nigeria Limited | 100% | Nigeria | ||
Distribution and sales of pharamaceutical products | ||||
The Company has control over the three subsidiaries and has consolidated them in the current year.
The investment is represented by one million ordinary shares of N1 each in Osworth Nigeria Limited, Tydipack Nigeria Limited and Servisure Nigeria Limited. The investment is carried at cost.
The Group | The Company | |||||||
September | December | September | September | December | September | |||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | |||
20. | Inventories | |||||||
Raw/packaging materials | 868,687 | 3,249,671 | 3,212,480 | 868,687 | 3,249,671 | 3,212,480 | ||
Work-in-progress | 281,383 | 426,041 | 134,820 | 281,383 | 426,041 | 134,820 | ||
Finished goods | 3,213,484 | 3,724,323 | 4,288,493 | 2,640,927 | 3,077,462 | 3,908,011 | ||
Spare parts/consumables | 982,950 | 843,652 | 600,847 | 918,864 | 785,710 | 550,743 | ||
5,346,503 | 8,243,687 | 8,236,640 | 4,709,860 | 7,538,884 | 7,806,054 | |||
Stock write down | - | - | - | - | ||||
5,346,503 | 8,243,687 | 8,236,640 | 4,709,860 | 7,538,884 | 7,806,054 | |||
There are no inventories pledged as security for liabilities.
The amount charged to profit or loss in respect of write down of inventory to net realisable value is Nil ( September, 2024 : Nil).
September | The Group December | September | September | The Company December | September | ||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
21. Trade and other receivables | |||||||
21.1 Trade receivables | |||||||
Trade receivables | 2,751,347 | 1,814,415 | 1,618,015 | 2,309,261 | 1,569,378 | 1,260,096 | |
Less: allowance for doubtful debts | (345,549) | (386,061) | (389,961) | (314,906) | (355,418) | (361,732) | |
2,405,798 | 1,428,354 | 1,228,054 | 1,994,355 | 1,213,960 | 898,364 | ||
21.2 Other receivables: Staff loans and advances | 221,269 | 153,891 | 186,962 | -193,639 | 128,563 | -163,525 | |
Sundry Receivables | 85,922 | 31,215 | 94,693 | 85,235 | 30,528 | 94,693 | |
Witholding tax recoverable | 180,587 | 158,230 | 143,217 | 157,345 | 136,757 | 122,927 | |
Due from related companies | 132,117 | 88,354 | 71,792 | 387,273 | 107,382 | 194,595 | |
619,895 | 431,689 | 496,664 | 823,493 | 403,230 | 575,740 | ||
Less: allowance for doubtful debt | (239,716) | (239,716) | (219,393) | (219,927) | (219,927) | (199,304) | |
380,179 | 191,973 | 277,271 | 603,565 | 183,303 | 376,436 | ||
Total trade and other receivables | 2,785,977 | 1,620,327 | 1,505,325 | 2,597,920 | 1,397,262 | 1,274,800 |
21.3 Trade receivables
Trade and other receivables disclosed above are carried at cost less allowance for doubtful debts.
The average credit period taken on sales of goods is between 30-45 days. No interest is charged on the overdue receivables. The Group has recognised an allowance for doubtful debts of 100% against all receivables over 360 days(excluding public sector and Institutions) because historical experience has been that receivables that are past due beyond 360 days may be doubtful of recovery. In most cases these debts are recovered.
Before accepting any new customer, the company uses an internal credit scoring system to assess the potential customer's credit quality and defines credit limits by customer. The internal credit scoring system are constantly reviewed.
The Group September December September | September | The Company December | September | |||||
2025 2024 2024 | 2025 | 2024 | 2024 | |||||
N'000 N'000 N'000 | N'000 | N'000 | N'000 | |||||
21. | Trade and other receivables (Cont'd) | |||||||
Ageing of receivables: 0-30 days | 1,307,812 | 281,709 | 428,781 | 1,074,512 | 182,022 | 154,193 | ||
31-60 days | 475,533 | 474,603 | 444,135 | 387,209 | 418,867 | 417,413 | ||
61-90 days | 219,966 | 363,278 | 153,927 | 178,497 | 304,005 | 147,623 | ||
91-150 days | 147,690 | 220,704 | 109,256 | 111,686 | 203,564 | 93,967 | ||
150-360 days | 240,139 | 148,804 | 234,844 | 222,943 | 136,777 | 199,828 | ||
Over 360 days | 360,208 | 324,681 | 247,072 | 334,414 | 323,506 | 247,072 | ||
Total | 2,751,348 | 1,813,778 | 1,618,015 | 2,309,261 | 1,568,741 | 1,260,096 | ||
In determining the recoverability of a trade receivable the Group considers any change in the credit quality of the trade receivable from the date credit was initially granted up to the reporting date. The concentration of credit risk is limited due to the customer base being large and unrelated.
September | The Group December | September | September | The Company December | September | ||
2025 | 2024 | 2024 | 2025 | 2024 | 2024 | ||
N'000 | N'000 | N'000 | N'000 | N'000 | N'000 | ||
Movement in the allowance for doubtful debts | |||||||
At 1 January | 625,777 | 644,271 | 644,271 | 575,345 | 596,083 | 595,953 | |
Impairment losses recognised /(write back) | - | 20,753 | - | - | 20,623 | - | |
Bad debt written off in the year | (40,511) | (39,247) | (34,917) | (40,511) | (41,361) | (34,917) | |
Amounts recovered during the year | - | - | - | - | - | - | |
Total | 585,266 | 625,777 | 609,354 | 534,834 | 575,345 | 561,036 |
The directors consider that the carrying amount of trade and other receivables is approximately equal to their fair value.
| Attention: This is an excerpt of the original content. To continue reading it, access the original document here. |
